Table 2.
Comparison of variables among blood glucose levels on admission
| Blood glucose on admission <200 N=738 | Blood glucose on admission ≥200 N=418 | P | |
|---|---|---|---|
| Demographics | |||
| Age | 55.78±17.16 | 56.09±16.61 | 0.7698 |
| BMI upon first admission | 32.32±9.81 | 30.73±7.78 | 0.0032 |
| Ethnicity, N (%) | <0.0001 | ||
| African-American | 91 (12.4) | 48 (11.6) | |
| Caucasian | 158 (21.5) | 44 (10.6) | |
| Hispanic | 444 (60.4) | 309 (74.6) | |
| Other | 42 (5.7) | 13 (3.1) | |
| Male (%) | 406 (55) | 233 (55.7) | 0.8109 |
| Medical comorbidities, N (%) | |||
| Deep venous thrombosis | 22 (3) | 19 (4.6) | 0.1611 |
| Pulmonary embolism | 7 (1) | 5 (1.2) | 0.7649 |
| Cerebral vascular accident | 13 (1.8) | 8 (1.9) | 0.8419 |
| Haemorrhagic stroke | 7 (1) | 1 (0.2) | 0.2709 |
| Disseminated intravascular coagulation | 5 (0.7) | 4 (1) | 0.7302 |
| Cancer | 27 (3.7) | 7 (1.7) | 0.0551 |
| Hypertension | 140 (19) | 84 (20.1) | 0.6418 |
| Obesity overweight—BMI >30 | 164 (22.2) | 75 (17.9) | 0.0843 |
| Chronic lung disease | 37 (5) | 17 (4.1) | 0.4637 |
| Cirrhosis | 7 (1) | 9 (2.2) | 0.0921 |
| Liver disease | 30 (4.1) | 11 (2.6) | 0.2055 |
| Myocardial infarction | 11 (1.5) | 10 (2.4) | |
| Chronic kidney disease | 65 (8.8) | 31 (7.4) | 0.4101 |
| End stage renal disease | 47 (6.4) | 18 (4.3) | 0.1436 |
| Prior anticoagulation use | 55 (7.5) | 32 (7.7) | 0.9226 |
| Hospitalization outcomes, N (%) | |||
| Mortality | 138 (18.7) | 107 (25.6) | 0.0058 |
| Limb ischaemia | 3 (0.4) | 3 (0.7) | 0.6731 |
| Respiratory treatment | 0.0381 | ||
| Room air | 181 (24.6) | 106 (25.4) | |
| Low-flow oxygen | 297 (40.4) | 145 (34.7) | |
| High-flow Oxygen | 116 (15.8) | 58 (13.9) | |
| NIMV | 44 (6) | 27 (6.5) | |
| Intubated | 97 (13.2) | 82 (19.6) | |
NIMV, Non invasive mask ventilation.